Genomic classification of T-cell acute lymphoblastic leukemia: Current paradigms and future biomarkers
Last Updated: Tuesday, July 1, 2025
This article highlights recent advancements in understanding T-cell acute lymphoblastic leukemia’s (T-ALL) disease biology and risk stratification, contrasting T-ALL with B-ALL, where risk stratification is more established, and explains how genomic initiatives are identifying biomarkers for improved T-ALL outcome prediction.
Advertisement
News & Literature Highlights